Published in World J Gastrointest Pharmacol Ther on August 06, 2014
Hepatorenal syndrome: Update on diagnosis and treatment. World J Nephrol (2015) 0.84
Baseline Chronic Kidney Disease and Ischemic Method of Partial Nephrectomy Are Important Factors for the Short- and Long-Term Deterioration in Renal Function for Renal Cell Carcinoma Staged T1-T2: A Retrospective Single Center Study. Biomed Res Int (2016) 0.75
The evolving concept of acute kidney injury in patients with cirrhosis. Nat Rev Gastroenterol Hepatol (2015) 0.75
Outcomes of liver transplantation in patients with hepatorenal syndrome. World J Hepatol (2016) 0.75
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care (2007) 29.89
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med (1993) 18.15
Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology (2003) 10.11
Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis (2009) 6.99
The RIFLE criteria and mortality in acute kidney injury: A systematic review. Kidney Int (2007) 6.35
Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med (1999) 5.89
EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol (2010) 4.55
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology (1996) 4.54
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut (2007) 4.51
Renal failure in cirrhosis. N Engl J Med (2009) 4.46
Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites. J Hepatol (2013) 4.24
A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant (2007) 4.11
A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis. J Hepatol (2013) 3.41
Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes. Kidney Int (2011) 2.94
Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology (2008) 2.89
A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology (2008) 2.69
Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut (2011) 2.65
Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study. J Hepatol (2011) 2.59
Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study. Hepatology (2002) 2.56
Acute kidney injury in cirrhosis. Hepatology (2008) 2.43
Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology (2013) 2.33
Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology (2002) 2.25
Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension. Hepatology (2010) 2.22
Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics. J Hepatol (2010) 2.16
Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study. J Hepatol (2007) 2.12
The evaluation of renal function and disease in patients with cirrhosis. J Hepatol (2010) 2.10
Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology (2004) 2.05
Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology (2012) 2.01
Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl (2007) 1.87
Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology (1998) 1.87
Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK). Am J Transplant (2008) 1.81
Intra-abdominal Hypertension and Abdominal Compartment Syndrome. Am J Kidney Dis (2011) 1.81
Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome. Hepatology (2010) 1.77
Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis (2003) 1.74
Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology (1999) 1.74
Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol (2010) 1.62
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology (2000) 1.55
Continuous terlipressin infusion in patients with septic shock: less may be best, and the earlier the better? Intensive Care Med (2007) 1.55
Glomerular hyperfiltration in patients with well-compensated alcoholic cirrhosis. Gastroenterology (1993) 1.55
Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transplant (2012) 1.50
Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther (2007) 1.45
Assessment of prognosis of cirrhosis. Semin Liver Dis (2008) 1.38
New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology (2013) 1.35
Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care (2012) 1.30
The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis. Intensive Care Med (2005) 1.29
RIFLE classification can predict short-term prognosis in critically ill cirrhotic patients. Intensive Care Med (2007) 1.28
Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis. J Hepatol (2004) 1.28
Female liver transplant recipients with the same GFR as male recipients have lower MELD scores--a systematic bias. Am J Transplant (2007) 1.25
Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score. Liver Transpl (2010) 1.24
Simultaneous liver-kidney transplantation: evaluation to decision making. Am J Transplant (2007) 1.22
Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology (2010) 1.21
Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis. Hepatology (2013) 1.18
Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver. Gut (2002) 1.17
Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med (1995) 1.14
Acute kidney injury: classification and staging. Contrib Nephrol (2010) 1.14
Octreotide/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Dig Dis Sci (2007) 1.13
Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis. Dig Dis Sci (2012) 1.12
Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis. Clin J Am Soc Nephrol (2010) 1.12
Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis. J Hepatol (2012) 1.12
Pitfalls in assessing renal function in patients with cirrhosis--potential inequity for access to treatment of hepatorenal failure and liver transplantation. Nephrol Dial Transplant (2011) 1.12
Kidneys in chronic liver diseases. World J Gastroenterol (2012) 1.10
RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit. J Gastroenterol Hepatol (2009) 1.08
Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol (2010) 1.05
Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations. Hepatology (2014) 1.05
Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing. J Hepatol (2002) 1.04
Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality. Eur J Gastroenterol Hepatol (2009) 1.04
Transjugular versus percutaneous renal biopsy for the diagnosis of parenchymal disease: comparison of sampling effectiveness and complications. Radiology (2000) 1.04
Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology (1995) 1.03
Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Hepatogastroenterology (2003) 1.02
Focusing on the clinical impact of standardization of creatinine measurements: a report by the EFCC Working Group on Creatinine Standardization. Clin Chem Lab Med (2011) 1.01
Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol (2010) 1.01
Identification of patients best suited for combined liver-kidney transplantation: part II. Liver Transpl (2002) 1.01
Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study. J Hepatol (2012) 1.00
Analysis of glomerular filtration rate, serum cystatin C levels, and renal resistive index values in cirrhosis patients. Clin Chem Lab Med (2007) 1.00
Acute kidney injury network criteria as a predictor of hospital mortality in cirrhotic patients with ascites. J Clin Gastroenterol (2012) 0.99
Current concepts in the diagnosis and classification of renal dysfunction in cirrhosis. Am J Nephrol (2013) 0.97
Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology (1995) 0.97
Rifaximin improves systemic hemodynamics and renal function in patients with alcohol-related cirrhosis and ascites. Clin Gastroenterol Hepatol (2012) 0.97
Acute renal failure: possible role of duplex Doppler US in distinction between acute prerenal failure and acute tubular necrosis. Radiology (1991) 0.96
Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis. Int Urol Nephrol (2010) 0.96
Outcome predictors and new score of critically ill cirrhotic patients with acute renal failure. Nephrol Dial Transplant (2008) 0.95
Improvement of hepatic encephalopathy by application of peritoneal dialysis in a patient with non-end-stage renal disease. Perit Dial Int (2013) 0.93
Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study. Hepatology (2003) 0.93
Hepatorenal syndrome. World J Gastroenterol (2012) 0.93
Risk models and scoring systems for predicting the prognosis in critically ill cirrhotic patients with acute kidney injury: a prospective validation study. PLoS One (2012) 0.93
Terlipressin for hepatorenal syndrome: A meta-analysis of randomized trials. Int J Artif Organs (2009) 0.92
Current management of hepatitis B virus infection before and after liver transplantation. Liver Int (2009) 0.92
Elevation of serum cystatin C concentrations in patients with chronic liver disease. Eur J Gastroenterol Hepatol (2001) 0.92
Hepatorenal syndrome, MELD score and liver transplantation: an evolving issue with relevant implications for clinical practice. J Hepatol (2012) 0.91
Outcome scoring systems for short-term prognosis in critically ill cirrhotic patients. Shock (2011) 0.90
Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels. Liver Int (2009) 0.90
Renal failure in patients with cirrhosis. Med Clin North Am (2009) 0.90
Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis. Hepatology (2004) 0.89
Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study. Nephrol Dial Transplant (2005) 0.89
The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt. Gastroenterology (1997) 0.88
Μanagement of patients with hepatitis B and C before and after liver and kidney transplantation. World J Hepatol (2014) 0.80